Does anyone have any insight on how cognitive testing will be affected when there's a blood test that can detect biomarkers for AD?
Would they complement each other? or would the need for cognitive testing fade over time?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.005(0.28%) |
Mkt cap ! $305.5M | |||
| Open | High | Low | Value | Volume |
| $1.80 | $1.82 | $1.78 | $95.65K | 53.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4401 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 3450 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |